WallStreetZenWallStreetZen

NASDAQ: GTBP
Gt Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gt Biopharma earnings were -$13.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GTBP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.8M, up 10.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GTBP reported annual earnings of -$13.2M, with 73.3% growth. The next GTBP earnings date is May 13, 2025.

GTBP earnings history

Current Revenue
$0.0
Current Earnings
-$13.2M
Current Profit Margin
0%

GTBP Return on Equity

Current Company
-468.1%
Current Industry
-2%
Current Market
34.1%
GTBP's Return on Equity (-468.1%)... subscribe to Premium to read more.
High Return on Equity Performance

GTBP undefined

Current Company
-174.5%
Current Industry
-0.4%
GTBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GTBP announces earnings.

GTBP undefined

Current Company
788.14%
Current Industry
5.9%
GTBP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GTBP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GTBP-$13.16M-$13.16MN/A-$6.94
APM-$3.82M-$4.27MN/A-$0.78
IBO-$22.49M-$24.71MN/A-$2.30
AZTR-$8.50M-$8.97MN/A-$2.37
CERO-$6.72M-$10.52MN/A-$18.15
View Top Biotech Stocks

GTBP earnings dates

Next earnings date
May 13, 2025

Gt Biopharma Earnings Reports & History FAQ

What were Gt Biopharma's earnings last quarter?

On GTBP's earnings call on Invalid Date, Gt Biopharma (NASDAQ: GTBP) reported Q4 2024 earnings per share (EPS) of -$1.66, up 23.5% year over year. Total GTBP earnings for the quarter were -$3.78 million. In the same quarter last year, Gt Biopharma's earnings per share (EPS) was -$2.17.

If you're new to stock investing, here's how to buy Gt Biopharma stock.

When does Gt Biopharma report earnings?

The next GTBP earnings call is Invalid Date. Add GTBP to your watchlist to be reminded of Gt Biopharma's next earnings date.

Is Gt Biopharma profitable or losing money?

As of the last Gt Biopharma earnings report, Gt Biopharma is currently losing money. Gt Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$13.16 million, a 73.25% increase year over year.

What was GTBP's earnings growth in the past year?

As of Gt Biopharma's earnings date in Invalid Date, Gt Biopharma's earnings has grown year over year. GTBP earnings in the past year totalled -$13.16 million.

What are Gt Biopharma's earnings expectations?

The current EPS estimate for Gt Biopharma's earnings report in Invalid Date is -$2.70.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.